Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis
- PMID: 20237938
- DOI: 10.1007/s00423-010-0622-5
Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis
Abstract
Introduction: The purpose of this review is to highlight the molecular mechanisms leading to the development and progression of pancreatic ductal adenocarcinoma (PDAC) with particular emphasis on tumor cell proliferation, local invasion, and metastasis. Recent advances in the field of PDAC biology have shed light on the molecular events that trigger PDAC initiation and maintenance.
Results: It is now clear that apart from the genetic alterations within the tumor cells, interactions of the tumor with its environment are necessary for proliferation and invasion. Interestingly, a number of developmental signaling pathways are reactivated in PDAC. Progress has also been made in the understanding of the molecular events that govern the process of metastasis.
Conclusion: Although our understanding of the mechanisms underlying PDAC pathobiology are more advanced than ever, little progress has been made in the clinical treatment of PDAC, and successful bench-to-bedside transfer of knowledge to boost new treatment options is still unsatisfying.
Similar articles
-
High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma.J Transl Med. 2015 Apr 30;13:137. doi: 10.1186/s12967-015-0490-4. J Transl Med. 2015. PMID: 25925763 Free PMC article.
-
Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.World J Gastroenterol. 2015 Aug 21;21(31):9348-57. doi: 10.3748/wjg.v21.i31.9348. World J Gastroenterol. 2015. PMID: 26309360 Free PMC article.
-
Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer.Semin Cancer Biol. 2017 Jun;44:43-59. doi: 10.1016/j.semcancer.2017.04.006. Epub 2017 Apr 22. Semin Cancer Biol. 2017. PMID: 28438662 Review.
-
MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes.Oncogene. 2015 Sep 10;34(37):4867-78. doi: 10.1038/onc.2014.408. Epub 2014 Dec 15. Oncogene. 2015. PMID: 25500542 Free PMC article.
-
An update on molecular research of pancreatic adenocarcinoma.Anticancer Agents Med Chem. 2011 Jun;11(5):411-7. doi: 10.2174/187152011795677409. Anticancer Agents Med Chem. 2011. PMID: 21492076 Review.
Cited by
-
The proline TP53 variant stimulates likely lymphangiogenesis in an orthotopic mouse model of pancreatic cancer.Br J Cancer. 2012 Jan 17;106(2):348-57. doi: 10.1038/bjc.2011.521. Epub 2011 Dec 6. Br J Cancer. 2012. PMID: 22146521 Free PMC article.
-
The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer.PLoS One. 2022 Sep 20;17(9):e0273518. doi: 10.1371/journal.pone.0273518. eCollection 2022. PLoS One. 2022. PMID: 36126055 Free PMC article.
-
Anti-tumor effect and mechanism of cyclooxygenase-2 inhibitor through matrix metalloproteinase 14 pathway in PANC-1 cells.Int J Clin Exp Pathol. 2015 Feb 1;8(2):1737-42. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 25973062 Free PMC article.
-
TOB1 suppresses proliferation in K-Ras wild-type pancreatic cancer.Cancer Med. 2020 Feb;9(4):1503-1514. doi: 10.1002/cam4.2756. Epub 2019 Dec 31. Cancer Med. 2020. PMID: 31891232 Free PMC article.
-
Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers.Am J Cancer Res. 2011;1(6):787-805. Epub 2011 May 28. Am J Cancer Res. 2011. PMID: 22016827 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical